-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Targeted therapy with biological agents is currently a rapidly developing treatment method for RA with remarkable curative effe.
Biologics have the advantages of fast onset, obvious inhibition of bone destruction, less impact on metabolism, and less toxicity to liver and kidney , which can help us solve many problems in previous treatmen.
Biological preparations have the advantages of fast onset, obvious inhibition of bone destruction, little impact on metabolism, and less liver and kidney toxicit.
Infect
TNF-α inhibitors (including etanercept, adalimumab, and infliximab, e.
TNF-α inhibitors (including etanercept, adalimumab, and infliximab, e.
lymphoma
As the world's first fully human monoclonal antibody against TNF-α, adalimumab has a rapid onset of action and a lasting and stable effica.
Quality of Life
Infliximab is more expensive, and it is more often used in some patients with severe and intractable rheumati.
heart failure
There is no conclusive evidence that TNF-α inhibitors increase the risk of associated solid tumors or lymphoproliferative disorders, but patients with previous malignancies should be alert to the risk of recurren.
For patients with poor response to TNF-α antagonists, tocilizumab (Yamero) can be used, which requires intravenous injection once a mon.
For patients with poor response to TNF-α antagonists, tocilizumab (Yamero) can be used, which requires intravenous injection once a mon.
In adult patients with moderately or severely active RA who have not responded to other drugs, abatacept can be used to reduce signs and symptoms, delay the progression of structural damage caused by the disease, and improve physical functi.
In adult patients with moderately or severely active RA who have not responded to other drugs, abatacept can be used to reduce signs and symptoms, delay the progression of structural damage caused by the disease, and improve physical functi.
leave a message here
